These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12560244)

  • 1. Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab.
    Herbert KE; Prince HM; Westerman DA
    Blood; 2003 Feb; 101(4):1654. PubMed ID: 12560244
    [No Abstract]   [Full Text] [Related]  

  • 2. Red cell aplasia due to parvovirus b19 in a patient treated with alemtuzumab.
    Crowley B; Woodcock B
    Br J Haematol; 2002 Oct; 119(1):279-80. PubMed ID: 12358942
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma.
    Poplar S; Allford S; Rooney N
    Br J Haematol; 2010 Mar; 148(5):671. PubMed ID: 19681883
    [No Abstract]   [Full Text] [Related]  

  • 4. Parvovirus b19-associated pure red cell aplasia in chronic graft-versus-host disease.
    Hsu JW; Czander M; Anders V; Vogelsang G; Brodsky RA
    Br J Haematol; 2002 Oct; 119(1):280-1. PubMed ID: 12358943
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cheeks to red cell aplasia: parvovirus B19 in a heart transplant patient.
    Sadigh S; Frank D
    Blood; 2017 Aug; 130(8):1071. PubMed ID: 28838942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Posttransplant chronic anemia: parvovirus B19].
    Vincens NC; Carminatti M; Franco MF; Hallack Neto AE; Pinheiro HS
    J Bras Nefrol; 2012; 34(3):303-8. PubMed ID: 23099839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.
    Ideguchi H; Ohno S; Ishigatsubo Y
    Rheumatol Int; 2007 Feb; 27(4):411-4. PubMed ID: 17028860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with pure red cell aplasia after allogenic stem-cell transplantation. Parvo B19 infection.
    Berrevoets MA; van der Post RS; Schaap N
    Neth J Med; 2013 Sep; 71(7):370, 374. PubMed ID: 24038564
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
    Kishore J; Mukhopadhyay C
    Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
    Kaya B; Paydas S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Persistent influenza virus infection in a patient treated with alemtuzumab].
    Burrel S; Dilhuydy S; Bouabdallah K; Lafon MÉ; Milpied N; Fleury H
    Med Mal Infect; 2010 Nov; 40(11):657-9. PubMed ID: 20638206
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.
    Pitchaipillai S; Kelsey P; Haeney M
    Clin Lab Haematol; 2006 Oct; 28(5):347-50. PubMed ID: 16999728
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab.
    Sharma VR; Fleming DR; Slone SP
    Blood; 2000 Aug; 96(3):1184-6. PubMed ID: 10910942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroblastopenia and Parvovirus B19 infection in a healthy child.
    de Las Nieves López MA ; Medina Perez Mf ; Gónzalez Hermoso C
    Haematologica; 2000; 85(E-letters):E07. PubMed ID: 11114822
    [No Abstract]   [Full Text] [Related]  

  • 15. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.
    Elimelakh M; Dayton V; Park KS; Gruessner AC; Sutherland D; Howe RB; Reding MT; Eastlund T; van Burik JA; Singleton TP; Gruessner RW; Key NS
    Haematologica; 2007 Aug; 92(8):1029-36. PubMed ID: 17640860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure red cell aplasia due to parvovirus B19 infection in a renal transplant patient: a case report.
    So BJ; Chae KM; Lee KK; Lee YJ; Jeong BH
    Transplant Proc; 2000 Nov; 32(7):1954-6. PubMed ID: 11120017
    [No Abstract]   [Full Text] [Related]  

  • 17. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.
    Hayes-Lattin B; Seipel TJ; Gatter K; Heinrich MC; Maziarz RT
    Am J Hematol; 2004 Mar; 75(3):142-5. PubMed ID: 14978694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha-interferon therapy.
    Martins A; Costa A; Oliveira MJ; Rodrigues M; Ribeiro AP; Silvestre F; Reis A
    Sangre (Barc); 1998 Feb; 43(1):67-9. PubMed ID: 9577184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial transient red cell aplasia from parvovirus B-19 infection].
    Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
    Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvovirus B19–induced pure red cell aplasia in a heart transplant recipient.
    Fong CY; Kaplan ZS
    Blood; 2012 Oct; 120(17):3395. PubMed ID: 23256205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.